EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases

Jeong-Hun Kang iD, Daisuke Asai iD, Riki Toita iD

Journal of Xenobiotics · 05.12.2023 · 13 (4) · 775-810

DOI: 10.3390/jox13040049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Xenobiotics, online erschienen am 05.12.2023. Verfasst von Jeong-Hun Kang und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Cerebral and Cardiovascular Center Research Institute, 6-1 Shinmachi, Kishibe, Osaka 564-8565, Japan. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 292 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cerebral and Cardiovascular Center, National Cerebral and Cardiovascular Center Research Institute KIBANKEIHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bisphenol A (BPA; 4,4′-isopropylidenediphenol) is a well-known endocrine disruptor. Most human exposure to BPA occurs through the consumption of BPA-contaminated foods. Cardiovascular or cardiometabolic diseases such as diabetes, obesity, hypertension, acute kidney disease, chronic kidney disease, and heart failure are the leading causes of death worldwide. Positive associations have been reported between blood or urinary BPA levels and cardiovascular or cardiometabolic diseases. BPA also induces disorders or dysfunctions in the tissues associated with these diseases through various cell signaling pathways. This review highlights the literature elucidating the relationship between BPA and various cardiovascular or cardiometabolic diseases and the potential mechanisms underlying BPA-mediated disorders or dysfunctions in tissues such as blood vessels, skeletal muscle, adipose tissue, liver, pancreas, kidney, and heart that are associated with these diseases.

Schlagwörter

Stichwörter der Autor:innen

cardiometabolic diseasescardiovascular diseasecellular signaling pathwayendocrine disruptorlipidmetabolism

Autor:innen und Institutionen

  • National Cerebral and Cardiovascular Center Research Institute, 6-1 Shinmachi, Kishibe, Osaka 564-8565, Japan.
  • Laboratory of Microbiology, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Tokyo 194-8543, Japan.
  • Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31 Midorigaoka, Osaka 563-8577, Japan.
  • AIST-Osaka University Advanced Photonics and Biosensing Open Innovation Laboratory, National Institute of Advanced Industrial Science and Technology (AIST), 2-1 Yamadaoka, Osaka 565-0871, Japan.

ORCID-Profile: Jeong-Hun Kang, Daisuke Asai, Riki Toita

Förderung

  • National Cerebral and Cardiovascular Center
  • National Cerebral and Cardiovascular Center Research Institute KIBANKEIHI

Zitieren

APA

Kang, J. H., Asai, D., & Toita, R. (2023). Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases. Journal of Xenobiotics, 13(4), 775-810. https://doi.org/10.3390/jox13040049

Vancouver

Kang JH, Asai D, Toita R. Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases. Journal of Xenobiotics. 2023;13(4):775-810. doi:10.3390/jox13040049

BibTeX
@article{Kang2023,
  author = {Kang, Jeong-Hun and Asai, Daisuke and Toita, Riki},
  title = {Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases},
  journal = {Journal of Xenobiotics},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {775--810},
  doi = {10.3390/jox13040049}
}
Kostenlos starten →